Cargando…
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccines
The development and use of antibacterial glycoconjugate vaccines have significantly reduced the occurrence of potentially fatal childhood and adult diseases such as bacteremia, bacterial meningitis, and pneumonia. In these vaccines, the covalent linkage of bacterial glycans to carrier proteins augme...
Autores principales: | Anish, Chakkumkal, Beurret, Michel, Poolman, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664855/ https://www.ncbi.nlm.nih.gov/pubmed/34893630 http://dx.doi.org/10.1038/s41541-021-00409-1 |
Ejemplares similares
-
Glycan and Protein Analysis of Glycoengineered Bacterial E. coli Vaccines by MALDI-in-Source Decay FT-ICR Mass Spectrometry
por: Nicolardi, Simone, et al.
Publicado: (2022) -
Development of an Efficacious, Semisynthetic Glycoconjugate
Vaccine Candidate against Streptococcus pneumoniae Serotype 1
por: Schumann, Benjamin, et al.
Publicado: (2018) -
Cross Reactive Material 197 glycoconjugate vaccines contain privileged conjugation sites
por: Möginger, Uwe, et al.
Publicado: (2016) -
Synthetic Glycans to Improve Current Glycoconjugate
Vaccines and Fight Antimicrobial Resistance
por: Del Bino, Linda, et al.
Publicado: (2022) -
Peptide adjacent to glycosylation sites impacts immunogenicity of glycoconjugate vaccine
por: Ma, Zhongrui, et al.
Publicado: (2017)